Article

Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery

Department of Molecular Biology and Microbiology, College of Medicine, University of Central Florida, Orlando, FL 32816-2364, USA.
Plant Biotechnology Journal (Impact Factor: 5.75). 02/2010; 8(2):223-42. DOI: 10.1111/j.1467-7652.2009.00479.x
Source: PubMed

ABSTRACT

Cholera and malaria are major diseases causing high mortality. The only licensed cholera vaccine is expensive; immunity is lost in children within 3 years and adults are not fully protected. No vaccine is yet available for malaria. Therefore, in this study, the cholera toxin-B subunit (CTB) of Vibrio cholerae fused to malarial vaccine antigens apical membrane antigen-1 (AMA1) and merozoite surface protein-1 (MSP1) was expressed in lettuce and tobacco chloroplasts. Southern blot analysis confirmed homoplasmy and stable integration of transgenes. CTB-AMA1 and CTB-MSP1 fusion proteins accumulated up to 13.17% and 10.11% (total soluble protein, TSP) in tobacco and up to 7.3% and 6.1% (TSP) in lettuce, respectively. Nine groups of mice (n = 10/group) were immunized subcutaneously (SQV) or orally (ORV) with purified antigens or transplastomic tobacco leaves. Significant levels of antigen-specific antibody titres of immunized mice completely inhibited proliferation of the malarial parasite and cross-reacted with the native parasite proteins in immunoblots and immunofluorescence studies. Protection against cholera toxin challenge in both ORV (100%) and SQV (89%) mice correlated with CTB-specific titres of intestinal, serum IgA and IgG1 in ORV and only IgG1 in SQV mice, but no other immunoglobulin. Increasing numbers of interleukin-10(+) T cell but not Foxp3(+) regulatory T cells, suppression of interferon-gamma and absence of interleukin-17 were observed in protected mice, suggesting that immunity is conferred via the Tr1/Th2 immune response. Dual immunity against two major infectious diseases provided by chloroplast-derived vaccine antigens for long-term (>300 days, 50% of mouse life span) offers a realistic platform for low cost vaccines and insight into mucosal and systemic immunity.

Download full-text

Full-text

Available from: Robert K Banks
  • Source
    • "for bioactivity such as pentamer assembly, disulphide bond formation, cyclization, protein lipidation and N-terminal methionine excision, but glycosylation does not occur in chloroplasts (Boyhan and Daniell, 2011; Davoodi-Semiromi et al., 2010; Kohli et al., 2014; Kwon et al., 2013a; Scotti et al., 2012; Sherman et al., 2014; Shil et al., 2014; Verma et al., 2010). The expression of a thioredoxin in chloroplasts enhanced protein solubility, proper folding and disulphide bond formation (Sanz-Barrio et al., 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Although the plant-made vaccine field started three decades ago with the promise of developing low-cost vaccines to prevent infectious disease outbreaks and epidemics around the globe, this goal has not yet been achieved. Plants offer several major advantages in vaccine generation, including low-cost production by eliminating expensive fermentation and purification systems, sterile delivery and cold storage/transportation. Most importantly, oral vaccination using plant-made antigens confers both mucosal (IgA) and systemic (IgG) immunity. Studies in the past 5 years have made significant progress in expressing vaccine antigens in edible leaves (especially lettuce), processing leaves or seeds through lyophilization and achieving antigen stability and efficacy after prolonged storage at ambient temperatures. Bioencapsulation of antigens in plant cells protects them from the digestive system; the fusion of antigens to transmucosal carriers enhances efficiency of their delivery to the immune system and facilitates successful development of plant vaccines as oral boosters. However, the lack of oral priming approaches diminishes these advantages because purified antigens, cold storage/transportation and limited shelf life are still major challenges for priming with adjuvants and for antigen delivery by injection. Yet another challenge is the risk of inducing tolerance without priming the host immune system. Therefore, mechanistic aspects of these two opposing processes (antibody production or suppression) are discussed in this review. In addition, we summarize recent progress made in oral delivery of vaccine antigens expressed in plant cells via the chloroplast or nuclear genomes and potential challenges in achieving immunity against infectious diseases using cold-chain-free vaccine delivery approaches.
    Full-text · Article · Sep 2015 · Plant Biotechnology Journal
  • Source
    • "In the past two decades, the concept of chloroplast genetic engineering has been advanced to achieve hyperexpression of foreign proteins, with recent advances in conferring novel agronomic traits (Clarke and Daniell, 2011; Jin et al., 2012; Lee et al., 2011), biomass/biofuel enhancement (Agrawal et al., 2011; Jin et al., 2011; Verma et al., 2010a, 2013) or for various biomedical applications for oral delivery of vaccines (Arlen et al., 2008; Davoodi-Semiromi et al., 2010; Lakshmi et al., 2013), autoantigens (Ruhlman et al., 2007; Sherman et al., 2014; Verma et al., 2010b) or biopharmaceuticals (Boyhan and Daniell, 2010; Kohli et al., 2014; Kwon et al., 2013a,c; Ruhlman et al., 2010; Shenoy et al., 2014; Shil et al., 2014). While application of RNAi technology through plant nuclear transformation has several limitations, delivery of small RNA prepared in more efficient systems as human therapeutics is also severely limited by their methods of delivery (Rothschild, 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In the past two decades, chloroplast genetic engineering has been advanced to achieve high-level protein accumulation but not for down-regulation of targeted genes. Therefore, in this report, lepidopteran chitin synthase (Chi), cytochrome P450 monooxygenase (P450) and V-ATPase dsRNAs were expressed via the chloroplast genome to study RNA interference (RNAi) of target genes in intended hosts. PCR and Southern blot analysis confirmed homoplasmy and site-specific integration of transgene cassettes into the chloroplast genomes. Northern blots and real-time qRT-PCR confirmed abundant processed and unprocessed dsRNA transcripts (up to 3.45 million copies of P450 dsRNAs/μg total RNA); the abundance of cleaved dsRNA was greater than the endogenous psbA transcript. Feeding of leaves expressing P450, Chi and V-ATPase dsRNA decreased transcription of the targeted gene to almost undetectable levels in the insect midgut, likely after further processing of dsRNA in their gut. Consequently, the net weight of larvae, growth and pupation rates were significantly reduced by chloroplast-derived dsRNAs. Taken together, successful expression of dsRNAs via the chloroplast genome for the first time opens the door to study RNA interference/processing within plastids. Most importantly, dsRNA expressed in chloroplasts can be utilized for gene inactivation to confer desired agronomic traits or for various biomedical applications, including down-regulation of dysfunctional genes in cancer or autoimmune disorders, after oral delivery of dsRNA bioencapsulated within plant cells. © 2015 The Authors. Plant Biotechnology Journal published by Society for Experimental Biology and The Association of Applied Biologists and John Wiley & Sons Ltd.
    Full-text · Article · Mar 2015 · Plant Biotechnology Journal
    • "Potrzeba uproszczenia dotychczasowych procedur uzyskiwania szczepionek i związana z tym szansa obniżenia rosnących kosztów produkcji skłoniły badaczy do poszukiwań alternatywnych strategii wobec metod tradycyjnych[86].i malarii czy podjednostka proinsuliny ludzkiej (białka fuzyjne odpowiednio: CTB:ama-1, CTB-msp-1 i CTB:Pins)[14,66].[64]peptyd PA toksyny Bacillus anthracis tytoń/b.d. wąglik[5]podjednostka B toksyny Vibrio cholereae (CTB) ryż cholera[60]DTP – kombinacja antygenów toksyn Diptheria, Tetanus, Pertussis tytoń/0,15% błonica tężec, krztusiec[8]Wirusowym antygen powierzchniowy wirusa zapalenia wątroby Typu B (HbsAG) m.in. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In recent years, there has been an increased interest of researchers in developing efficient plant heterologous expression systems of proteins for a wide range of applications. It represents an alternative to the traditional strategy utilizing bacterial, yeast, insect or mammalian cells. New techniques of identification and characterization and effective methods of plant genetic transformation allow the range of recombinant protein products to be expanded. Great expectations are associated with the use of plants as bioreactors for the production of specific proteins of therapeutic interest. This strategy offers a number of advantages, the most important being: the possibility of a significant reduction in production costs, the safety of the products obtained and full eukaryotic post-translational modifications of proteins. A group of proteins of special interest is pharmaceuticals, and a number of successful experiments have confirmed the possibility of obtaining heterogeneous proteins with therapeutic potential: monoclonal antibodies, vaccine antigens, and a variety of cytokines. This work is focused on selected recombinant proteins belonging to those groups expression of which was achieved in plant cells. These proteins may be used in the future for therapy or prevention of viral, bacterial or cancer diseases.
    No preview · Article · Jan 2015 · Postępy Higieny i Medycyny Doświadczalnej (Advances in Hygiene and Experimental Medicine)
Show more